A generic image of a stock chart
Markets

Keeley All Cap Value Fund Comments on Shire

Given the volatile Health Care sector this quarter, the Fund's position in Shire ( NASDAQ:SHPG ) was also a leading detractor. Headline risk regarding potential pharmaceutical price controls has impacted the stock. With continued synergies from its acquisition of Baxalta and trading at 11x earnings, we feel the stock remains quite attractive.

From the Keeley All Cap Value Fund fourth quarter 2016 commentary .

Premium Members

This article first appeared on GuruFocus .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

Stocks

Latest Markets Videos